Chemence Medical announced today that the FDA cleared its Exofin precision pen as a medical device for wound closure. Alpharetta, Georgia-based Chemence said in a news release that the Exofin precision pen offers more versatility and exactness in closing wounds while also improving the ease of use in applying topical skin adhesive. It is available […]
Chemence Medical Products
Chemence Medical wins FDA nod for Exofin Fusion skin closure system
Chemence Medical said today it won FDA clearance for its Exofin Fusion skin closure system designed for medium to large wounds. The Exofin Fusion skin closure system features a self-adhering mesh strip, mesh anchors and a fast-curing 2-octyl cyanoacrylate topical adhesive to close and seal large incisions and form a microbial barrier to protect from infections, […]
FDA clears Chemence’s Exofin tissue adhesive
Chemence Medical said yesterday it won FDA 510(k) for its Exofin topical skin adhesive designed for wound closure. The Alpharetta, Ga.-based company said it will offer the Exofin sealant in 2 sizes, and claimed the product is the “fastest polymerizing 2-octyl cyanoacrylate topical adhesive” available, with the highest viscosity formulation. “After spending more than 2 years […]
Medical device tax: Chemence must pay medtech tax in dispute with distributor Medline
Chemence Medical Products is on the hook for the 2.3% medical device tax on the medical adhesives it makes for distributor Medline Industries, a federal judge ruled this week.
